NRXP
Q4 2026 EPS Estimate
$-0.07
Nov 13, 2026
Revenue Estimate
$2M
FY2027E EPS$0.30
FY2028E EPS$2.49

Analyst Sentiment

Wall St. Consensus
Buy
5 analysts·Limited coverage
75
Score
5 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
-41.9%
Consensus
$2.00
-41.9%
Bull
$2.00
-41.9%
12-Month Target Range5 analysts
$2.00$2.00$2.00
Current $3.44Consensus
Current Price
$3.44
Above Consensus
$1.44

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+1657.70%
EPS
FY2028
Rev+178.45%
EPS+720.78%
FY2029
Rev+49.38%
EPS+81.12%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$10M$179M$499M$745M$935M
Low$9M$74M$348M$520M$653M
High$11M$284M$752M$1.12B$1.41B
EBITDA Avg$6M$107M$299M$447M$561M
Low$6M$44M$209M$312M$392M
High$7M$171M$451M$674M$846M
EBIT Avg$6M$107M$299M$447M$561M
Low$6M$44M$209M$312M$392M
High$7M$171M$451M$674M$846M
Net Income Avg$-8M$6M$60M$97M$123M
Low$-10M$6M$32M$59M$75M
High$-6M$7M$88M$160M$205M
EPS Avg$-0.38$0.30$2.49$4.51$5.76
Low$-0.45$0.26$1.51$2.74$3.50
High$-0.29$0.34$4.13$7.48$9.56
Analysts (Rev / EPS)2 / 23 / 21 / 11 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$2M$6M$32M$51M$70M$90M$274M$286M
Low$884,761$1M$12M$19M$27M$34M$104M$108M
High$2M$16M$67M$106M$146M$186M$568M$592M
EBITDA Avg$928,999$4M$19M$31M$42M$54M$165M$172M
Low$530,856$640,799$7M$12M$16M$20M$62M$65M
High$1M$10M$40M$64M$87M$111M$341M$355M
EBIT Avg$928,999$4M$19M$31M$42M$54M$165M$172M
Low$530,856$640,799$7M$12M$16M$20M$62M$65M
High$1M$10M$40M$64M$87M$111M$341M$355M
Net Income Avg$-4M$-4M$-84,071$2M$3M$7M$198M$206M
Low$-5M$-10M$-200,970$300,380$580,756$1M$38M$40M
High$-4M$-787,384$-16,149$4M$7M$16M$474M$493M
EPS Avg$-0.11$-0.11$-0.00$0.04$0.08$0.18$5.27$5.48
Low$-0.13$-0.26$-0.01$0.01$0.02$0.03$1.01$1.05
High$-0.10$-0.02$-0.00$0.10$0.19$0.42$12.59$13.10
Analysts (Rev / EPS)2 / 13 / 11 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jun 30, 2022H.C. Wainwright
NRx Pharmaceuticals (NRXP) Stock: Why It Increased Over 6% Today
Target:$2.00
+249.0%from $0.57
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.